Star Health and Allied Insurance Company Ltd (STARHEALTH) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- The company demonstrated strong performance in Q2 FY26, driven by a risk-first approach, focus on RoE, and customer-centricity, maintaining its market leadership in the retail health segment with a 32% market share.
- Significant improvement was seen in profitability metrics, with the net incurred claim ratio for Q2 FY26 decreasing by 190 basis points YoY to 71.8%, attributed to portfolio recalibration, exiting unprofitable group businesses, and repricing high-claim portfolios.
- The digital vertical emerged as the fastest-growing channel, with a 47% YoY growth in fresh premium, now contributing nearly 20% of the overall fresh business, highlighting a successful digital-first strategy.
- Operating efficiency improved, with the expense ratio declining to 29.3% for Q2 FY26 from 31.1% in Q2 FY25, driven by investments in technology, automation, and enhanced manpower productivity.
- The company anticipates a significant demand uptick following the GST waiver on retail health indemnity policies, with October already showing a 50% growth in fresh business, indicating improved affordability and strong underlying demand.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.